Publication | Closed Access
Intravenous immunoglobulin G use in patients with chronic inflammatory demyelinating polyneuropathy: An uncommon cause of drug‐induced discoid lupus erythematosus
10
Citations
5
References
2019
Year
VasculitisChronic InflammatoryImmunodeficienciesImmunologyDermatologyImmunotherapyInflammatory ArthritisUncommon CauseIga GlomerulonephritisInflammatory Rheumatic DiseaseNeurologyNeuropathologyNeuroimmunologyRheumatologyAutoimmune DiseaseSystemic Lupus ErythematosusSystemic Lupus Erythematosus TreatmentLupus NephritisIgg ImmunoglobulinAutoimmunityImmunologic DiseaseLupusLupus ErythematosusImmunosuppressionMedicine
Drug-induced chronic cutaneous lupus erythematosus, or drug-induced discoid lupus erythematosus, is a rare cutaneous phenomenon. Various medications have been associated with drug-induced discoid lupus erythematosus including fluorouracile agents, especially tegafur and uraciltegafur, and TNF-α antagonists such as infliximab or etanercept. Recent literature has described a case series of six patients receiving IgG immunoglobulin for chronic inflammatory demyelinating polyneuropathy with subsequent presentations of discoid lupus erythematosus. We present a patient with chronic inflammatory demyelinating polyneuropathy who developed discoid lupus erythematosus secondary to IgG immunoglobulin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1